Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Coeptis Therapeutics Holdings (COEPW) Long-Term Debt Issuances (2023 - 2025)

Coeptis Therapeutics Holdings has reported Long-Term Debt Issuances over the past 3 years, most recently at $990000.0 for Q1 2025.

  • Quarterly results put Long-Term Debt Issuances at $990000.0 for Q1 2025, down 26.67% from a year ago — trailing twelve months through Dec 2025 was $990000.0 (down 46.49% YoY), and the annual figure for FY2025 was $990000.0, down 46.49%.
  • Long-Term Debt Issuances for Q1 2025 was $990000.0 at Coeptis Therapeutics Holdings, up from $500000.0 in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for COEPW hit a ceiling of $1.3 million in Q1 2024 and a floor of $150000.0 in Q3 2023.
  • Median Long-Term Debt Issuances over the past 3 years was $425000.0 (2023), compared with a mean of $581666.7.
  • Biggest five-year swings in Long-Term Debt Issuances: soared 42.86% in 2024 and later dropped 26.67% in 2025.
  • Coeptis Therapeutics Holdings' Long-Term Debt Issuances stood at $150000.0 in 2023, then surged by 233.33% to $500000.0 in 2024, then surged by 98.0% to $990000.0 in 2025.
  • The last three reported values for Long-Term Debt Issuances were $990000.0 (Q1 2025), $500000.0 (Q2 2024), and $1.3 million (Q1 2024) per Business Quant data.